吉林长龙药业(08049)认购5000万元中国工商银行理财产品

Core Viewpoint - Jilin Changlong Pharmaceutical (08049) announced a subscription to a financial product from Industrial and Commercial Bank of China, amounting to RMB 50 million, scheduled for August 25, 2025 [1] Group 1 - The company is engaging in investment activities by subscribing to a financial product [1] - The total amount of the investment is RMB 50 million, which is a significant financial commitment [1] - The investment is set to mature on August 25, 2025, indicating a long-term financial strategy [1]